SG49658A1
(en )
1998-06-15
Treatment of condition and disease
EP0204597A3
(en )
1989-08-16
Use of alfuzosine in the treatment of urinary affections
EP0330496A3
(en )
1990-02-28
Skin treatment composition
EP0506893A4
(en )
1996-09-25
Diagnosis and treatment of diseases
EP0207614A3
(en )
1989-07-26
Use of benzopyran compounds in the treatment of incontinence
EP0453497A4
(en )
1992-10-07
Treatment methods and vaccines
EP0437026A3
(en )
1991-10-02
Use of tandospirone in the treatment of depression
GB2203645B
(en )
1990-10-24
Improvements in the treatment of hair
GB8708049D0
(en )
1987-05-07
Dental treatment
GB8804531D0
(en )
1988-03-30
Skin treatment formulations
ZA908490B
(en )
1991-07-31
Use of arylalkylamides in the treatment of neurodegenerative diseases
GB8714972D0
(en )
1987-08-05
Medical treatment
EP0436717A4
(en )
1993-03-24
Method of treatment with medical agents
IE893615L
(en )
1990-05-10
Use of edta in medical treatment
GB8915023D0
(en )
1989-08-23
Improvements in or relating to medical syringes
GB8908843D0
(en )
1989-06-07
Improvements in or relating to the treatment of surfaces
EP0407016A3
(en )
1991-11-06
Use of benzodioxinopyrrole derivatives in the treatment of anxiety
GB9010190D0
(en )
1990-06-27
Composition for the treatment of protozoal disease and their use
GR871756B
(en )
1987-11-26
The accupuncture and moxibustion medical treatment dedection dial
GB8925210D0
(en )
1989-12-28
Medical treatment
GB8910474D0
(en )
1989-06-21
Device for the use in treatment of the human body
GB8918242D0
(en )
1989-09-20
Preparation of agents for use in therapy
SG4695G
(en )
1995-06-16
Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases
ZA897601B
(en )
1991-09-25
Device for use in medical treatment
GB8916469D0
(en )
1989-09-06
Further medical use